Status:
COMPLETED
Reliability of Kinovea in Gait Assessment in Multiple Sclerosis: a Pilot Study.
Lead Sponsor:
University of Cadiz
Collaborating Sponsors:
Hospital Universitario Virgen Macarena
Conditions:
Multiple Sclerosis
Gait Disorders, Neurologic
Eligibility:
All Genders
18-55 years
Brief Summary
The objective of this observational study is to determine whether the Kinovea video analysis tool is valid and reliable for analyzing spatiotemporal gait parameters in multiple sclerosis, comparing th...
Eligibility Criteria
Inclusion
- Patients scheduled for evaluation by the NeuroLab-Lázaro gait laboratory (Seville).
- Patients who have signed informed consent prior to the test.
- Patients between 18 and 55 years of age, diagnosed with MS according to the 2017 McDonald criteria.
- Patients with an EDSS score of less than 6.5 points.
- Patients who are willing to participate in the study and who do not object to being recorded while performing the gait test and to the use of images for educational and research purposes.
Exclusion
- Patients who use walking aids and/or orthoses.
- Patients with comorbidity or decompensated systemic disease within the last month.
- Patients who have any physical impediment (excessive fatigue) to performing the gait test, as documented in their medical records reviewed on the Diraya platform.
- Patients who have suffered a relapse within 30 days prior to the start of the study.
Key Trial Info
Start Date :
March 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 2 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06928194
Start Date
March 10 2025
End Date
April 2 2025
Last Update
April 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NeuroLab-Lázaro
Seville, Sevilla, Spain, 41015